← Leaderboards
Jerilynn Radcliffe
Children'S Hospital Of Philadelphia
$940,553
Attributed
$940,553
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $202.2K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$940,553 · 2
By mechanism
U54$940,553 · 2
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Jeffrey H Silber$32,280,141
- Kathryn G Commons$6,280,807
- Kathleen Mary Loomes$9,589,475
- Kathleen E Sullivan$15,902,231
- Joseph J Zorc$1,027,220
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaAnalgesiaHealth EducationHuman Therapy EvaluationAdolescence (12-20)Human SubjectCooperative StudyPatient Oriented ResearchClinical TrialsAnxietyCognitiveEventControl GroupsControlled Clinical Trials, RandomizedAnalgesicsAdolescentChildhoodEducational CurriculumEducational AspectsChildEffect Modifiers (Epidemiology)EnrollmentDiariesDesign
Grant awards (5)
Controlled Pain Interaction for Adolescents with Sickle Cell Disease$171,487
U54 · FY2007 · HL · contact PI
Controlled Pain Interaction for Adolescents with Sickle Cell Disease$202,212
U54 · FY2006 · HL · contact PI
Controlled Pain Interaction for Adolescents with Sickle Cell Disease$197,646
U54 · FY2005 · HL
Controlled Pain Interaction for Adolescents with Sickle Cell Disease$199,434
U54 · FY2004 · HL
Controlled Pain Interaction for Adolescents with Sickle Cell Disease$169,774
U54 · FY2003 · HL